Was encouraged by the CEOs reassurance that we are well on track to achieve current years projections of $27-$30m. Seems the new diversification is kicking goals for the company without having to rely on major contracts. Major contracts will be cream.
In addition they they have an eye on possible affordable and complementary acquisitions.
Pet is fast developing into a strong truly diversified company and we should see the SP rise substantially as milestones are hit. Shareholders who are prepared to wait will be strongly rewarded in the medium term. Maybe the first reward will be the payment of dividends.
The only concern that I got was the need for capital to fund growth but if you are prepared to participate (and we get the opportunity) this should not be a problem.
First things first however. The market needs to settle from the current volatility. IMHO this is just a healthy correction as markets had been very strong of late. I see no reason to panic and in fact this could be a buying opportunity.
Time will tell
- Forums
- ASX - By Stock
- Ann: 2018 Annual Report
Was encouraged by the CEOs reassurance that we are well on track...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PET (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.60M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
PET (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online